SMT201600471T1 - Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche. - Google Patents

Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche.

Info

Publication number
SMT201600471T1
SMT201600471T1 SM20160471T SMT201600471T SMT201600471T1 SM T201600471 T1 SMT201600471 T1 SM T201600471T1 SM 20160471 T SM20160471 T SM 20160471T SM T201600471 T SMT201600471 T SM T201600471T SM T201600471 T1 SMT201600471 T1 SM T201600471T1
Authority
SM
San Marino
Prior art keywords
nalmefene
reduction
specific target
alcohol consumption
target populations
Prior art date
Application number
SM20160471T
Other languages
English (en)
Italian (it)
Inventor
Lars Torup
Afsaneh Abbariki
Anna Bladström
Christine Persson
Didier Meulien
Per Sørensen
Thomas Jon Jensen
Jette Buch Østergaard
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48703496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600471(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of SMT201600471T1 publication Critical patent/SMT201600471T1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SM20160471T 2012-06-27 2013-06-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche. SMT201600471T1 (it)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261664804P 2012-06-27 2012-06-27
US201261721539P 2012-11-02 2012-11-02
US201261736740P 2012-12-13 2012-12-13
US201361788810P 2013-03-15 2013-03-15
PCT/EP2013/063461 WO2014001427A1 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations
EP13732471.1A EP2866808B1 (en) 2012-06-27 2013-06-27 Nalmefene for reduction of alcohol consumption in specific target populations

Publications (1)

Publication Number Publication Date
SMT201600471T1 true SMT201600471T1 (it) 2017-03-08

Family

ID=48703496

Family Applications (3)

Application Number Title Priority Date Filing Date
SM20160471T SMT201600471T1 (it) 2012-06-27 2013-06-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche.
SM20180164T SMT201800164T1 (it) 2012-06-27 2013-06-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
SM201600471T SMT201600471B (it) 2012-06-27 2016-12-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche

Family Applications After (2)

Application Number Title Priority Date Filing Date
SM20180164T SMT201800164T1 (it) 2012-06-27 2013-06-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
SM201600471T SMT201600471B (it) 2012-06-27 2016-12-27 Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche

Country Status (35)

Country Link
US (4) US20140005216A1 (enExample)
EP (5) EP3138564B1 (enExample)
JP (3) JP6258933B2 (enExample)
KR (1) KR20150023396A (enExample)
CN (1) CN104411313A (enExample)
AU (1) AU2013283281B2 (enExample)
BR (1) BR112014032555A2 (enExample)
CA (1) CA2874703C (enExample)
CL (1) CL2014003484A1 (enExample)
CO (1) CO7160087A2 (enExample)
CY (3) CY1118579T1 (enExample)
DK (3) DK3345604T3 (enExample)
EA (1) EA029908B1 (enExample)
ES (4) ES3014068T3 (enExample)
FI (1) FI3345604T3 (enExample)
HK (1) HK1255683A1 (enExample)
HR (4) HRP20230762T8 (enExample)
HU (4) HUE031110T2 (enExample)
IL (1) IL236035B (enExample)
LT (3) LT2866808T (enExample)
ME (2) ME02587B (enExample)
MX (1) MX371373B (enExample)
MY (1) MY166914A (enExample)
NZ (1) NZ702191A (enExample)
PH (1) PH12014502798A1 (enExample)
PL (4) PL3345604T3 (enExample)
PT (3) PT3138564T (enExample)
RS (2) RS55456B1 (enExample)
RU (1) RU2665373C2 (enExample)
SG (1) SG11201408704WA (enExample)
SI (3) SI2866808T1 (enExample)
SM (3) SMT201600471T1 (enExample)
UA (1) UA114199C2 (enExample)
WO (1) WO2014001427A1 (enExample)
ZA (1) ZA201409525B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
WO2014170353A1 (en) * 2013-04-17 2014-10-23 H. Lundbeck A/S Nalmefene for treatment of patients with sleep disorder
AU2015250611A1 (en) 2014-04-22 2016-11-24 H. Lundbeck A/S Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
US20170071590A1 (en) * 2015-09-10 2017-03-16 Suture Armor Llc Suture anchor
KR102699603B1 (ko) 2018-04-20 2024-08-29 삼성전자주식회사 반도체 메모리 소자

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814768A (en) 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
US20030153590A1 (en) * 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
UA106752C2 (uk) 2009-05-25 2014-10-10 Х. Луннбек А/С Одержання налмефену гідрохлориду з налтрексону
EA022266B1 (ru) 2010-11-05 2015-11-30 Х. Лундбекк А/С Способ получения налтрексона
BR112013024137A2 (pt) 2011-03-31 2017-09-26 Imuneks Farma Ilac Sanayi Ve Ticaret A S composições de antagonistas de opióides e seu uso para o tratamento da esclerodermia
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations

Also Published As

Publication number Publication date
PT3138564T (pt) 2018-04-03
ZA201409525B (en) 2016-08-31
HUE070621T2 (hu) 2025-06-28
ES3014068T3 (en) 2025-04-16
EP2866808B1 (en) 2016-11-02
CA2874703A1 (en) 2014-01-03
EP3345604A1 (en) 2018-07-11
IL236035B (en) 2018-12-31
RS57046B1 (sr) 2018-05-31
CY1126140T1 (el) 2023-11-15
EA029908B1 (ru) 2018-05-31
BR112014032555A2 (pt) 2017-06-27
PT2866808T (pt) 2017-01-03
RU2665373C2 (ru) 2018-08-29
SI2866808T1 (sl) 2017-01-31
CN104411313A (zh) 2015-03-11
JP2019163275A (ja) 2019-09-26
ES2663532T3 (es) 2018-04-13
HRP20250329T1 (hr) 2025-05-09
PL2866808T3 (pl) 2017-04-28
EP3138564B1 (en) 2018-01-31
DK2866808T3 (en) 2017-01-16
CA2874703C (en) 2022-08-23
SI3345604T1 (sl) 2023-08-31
US20180028526A1 (en) 2018-02-01
PT3345604T (pt) 2023-07-17
EP4223296A3 (en) 2023-09-27
JP2018039810A (ja) 2018-03-15
EP4541421A3 (en) 2025-06-18
US9642849B2 (en) 2017-05-09
ES2950492T3 (es) 2023-10-10
PL4223296T3 (pl) 2025-04-14
SMT201600471B (it) 2017-03-08
PL3138564T3 (pl) 2018-06-29
HRP20230762T8 (hr) 2024-01-05
SMT201800164T1 (it) 2018-07-17
US20140005216A1 (en) 2014-01-02
HRP20161717T1 (hr) 2017-02-10
MX371373B (es) 2020-01-28
HK1208185A1 (en) 2016-02-26
EP2866808A1 (en) 2015-05-06
NZ702191A (en) 2017-06-30
HUE031110T2 (en) 2017-06-28
EP4541421A2 (en) 2025-04-23
JP6258933B2 (ja) 2018-01-10
US20140005217A1 (en) 2014-01-02
AU2013283281A1 (en) 2014-12-11
SI3138564T1 (en) 2018-04-30
LT3138564T (lt) 2018-04-10
EA201492152A1 (ru) 2015-11-30
HUE063313T2 (hu) 2024-01-28
HK1255683A1 (en) 2019-08-23
DK3138564T3 (en) 2018-03-26
ME03030B (me) 2018-10-20
PH12014502798A1 (en) 2015-02-09
US20160375007A1 (en) 2016-12-29
JP2015521647A (ja) 2015-07-30
MX2014015488A (es) 2015-03-06
SG11201408704WA (en) 2015-01-29
CY1118579T1 (el) 2017-07-12
HRP20230762T1 (hr) 2023-10-13
CO7160087A2 (es) 2015-01-15
IL236035A0 (en) 2015-01-29
HRP20180363T1 (hr) 2018-04-20
DK3345604T3 (da) 2023-07-24
RU2014151156A (ru) 2016-08-20
ME02587B (me) 2017-06-20
FI3345604T3 (fi) 2023-07-28
EP4223296C0 (en) 2025-01-29
EP4223296B1 (en) 2025-01-29
CY1120097T1 (el) 2018-12-12
UA114199C2 (uk) 2017-05-10
HUE036272T2 (hu) 2018-06-28
ES2609122T3 (es) 2017-04-18
CL2014003484A1 (es) 2015-02-27
EP3138564A1 (en) 2017-03-08
AU2013283281B2 (en) 2017-04-20
LT2866808T (lt) 2017-01-10
EP4223296A2 (en) 2023-08-09
JP6857684B2 (ja) 2021-04-14
PL3345604T3 (pl) 2023-08-28
KR20150023396A (ko) 2015-03-05
WO2014001427A1 (en) 2014-01-03
MY166914A (en) 2018-07-24
LT3345604T (lt) 2023-08-10
EP3345604B1 (en) 2023-06-07
US10034874B2 (en) 2018-07-31
RS55456B1 (sr) 2017-04-28

Similar Documents

Publication Publication Date Title
EP3008215A4 (en) Statistical analysis for non-invasive sex chromosome aneuploidy determination
DK3542843T3 (da) Engangsinjektionspen til flere anvendelser
EP2875758A4 (en) JUICER
DK2914965T3 (da) Aflukker til biologiske mikroobjekter
IT1399629B1 (it) Laminatoio per manufatti allungati.
EP2853543A4 (en) ANTI-BLYS ANTIBODY
DK2670587T3 (da) Tabletpresse
EP2832108A4 (en) DYNAMIC SEARCH SERVICE
ITRM20130667A1 (it) Impianto di alimentzione di caburante.
SMT201600471B (it) Nalmefene per la riduzione del consumo di alcool in popolazioni bersaglio specifiche
ITRM20120601A1 (it) Formatore di spalla.
FI9797U1 (fi) Paineenkorotusyksikkö
CO7020922A2 (es) Comprimido antiácido
EP3052013A4 (en) Voxel-resolution myocardial blood flow analysis
TH1401003484A (th) องค์ประกอบไบโอแอคทีฟซึ่งมีแอดทิวิตีต้านการเสื่อมตามวัยของผม
GB201109110D0 (en) Multi search, social share & multi check out
IT1404226B1 (it) Procedimento per la produzione di fibrocemento ecologico, fibrocemento ottenuto e suoi impieghi.
ITRA20120006U1 (it) Meccanismo per mobili.
AU2012901035A0 (en) Local Sex Search
GB201319107D0 (en) Improvements relating to personal tracking identifiers
ES1094505Y (es) Pieza para separar el busto femenino
ITPD20130041U1 (it) Gruppo di presa a ventose particolarmente per la presa di corpi lastriformi.
BRDI7104802S (pt) Configuração aplicada em estantes.
ITMI20121124A1 (it) Articolo di gioielleria.